Global Cell Dissociation Market Report and Forecast 2024-2032

Global Cell Dissociation Market Outlook

The global cell dissociation market size was valued at USD 456.1 million in 2023, driven by the increasing prevalence of cancer, and neurological disorders across the globe. The market size is anticipated to grow at a CAGR of 15% during the forecast period of 2024-2032 to achieve a value of USD 1606.6 million by 2032.

Cell Dissociation: Introduction

The process of cell dissociation is crucial for studying tissue phenotypes. The technique used to extract cells from solid tissues has a significant impact on the types of cells obtained. The methodology employed also affects any biases introduced that can influence cell surface protein phenotypes or gene expression.

Global Cell Dissociation Market Analysis

The approval of pembrolizumab (Keytruda, Merck) by the Food and Drug Administration on November 16, 2023, for the first-line treatment of adults with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma is poised to significantly impact the global cell dissociation market.

Stem cell research, with its focus on the potential medical applications of stem cells, has been witnessing increased emphasis and demand for creating cell-based therapies, bolstering the global cell dissociation market growth. As stem cell research expands, the necessity for advanced techniques like cell dissociation becomes paramount, particularly in isolating and harvesting stem cells from tissues. The efficiency of cell dissociation methods is crucial for maintaining the viability and functionality of stem cells during the isolation process.

The FDA approval of pembrolizumab, specifically for a subtype of cancer, is expected to fuel the expansion of the market for research related to gastric and gastroesophageal junction adenocarcinoma. This expansion is anticipated to drive a surge in research activities, leading to an increased demand for cell dissociation tools and technologies. The combination of growing stem cell research and the specific market expansion prompted by the approval of pembrolizumab aligns with the trajectory of increased clinical trials, FDA approvals, and strategic initiatives by leading companies, collectively contributing to the robust growth of the global cell dissociation market.

Global Cell Dissociation Market Segmentations

Market Breakup by Type

• Trypsin

• Papain

• DNase

• Hyaluronidase

• Instruments

Market Breakup by Tissue Type 

• Connective Tissue

• Epithelial Tissue

Market Breakup by End User

• Pharma

• Biopharma

• Research Institutes

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

Global Cell Dissociation Market Overview

The market has been witnessing substantial growth driven by the increasing prevalence of various medical conditions including cancer, neurological disorders, cardiovascular diseases, genetic disorders, rare diseases, infectious diseases, regenerative medicine, and autoimmune diseases. Researchers leverage cell dissociation techniques across these diverse fields to isolate and study specific cell types, unravelling disease mechanisms and testing potential therapies.

The rising interest in personalized medicine and regenerative medicine is acting as a catalyst, propelling the demand for cell dissociation solutions. Furthermore, the market is benefiting from continuous technological advancements in cell dissociation products, particularly the development of reagents and kits that offer efficient cell dissociation. These innovations are anticipated to boost their usage in research and development applications.

Geographically, North America has been a leading regional market, expected to maintain its dominance throughout the forecast period as well. This dominance can be attributed to the increasing prevalence of cancer and neurological disorders in the region, driving a surge in research activities. The pursuit of finding the most suitable treatments for patients suffering from various medical conditions is bolstering market growth in North America.

The global cell dissociation market is poised for significant expansion as it becomes an integral component of cutting-edge research endeavours, addressing the growing demand for advanced solutions in the diagnosis, treatment, and understanding of complex diseases.

Global Cell Dissociation Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Merck KGaA

• Danaher Corporation

• Thermo Fisher Scientific, Inc

• Corning Incorporated

• Becton, Dickinson and Company

• STEMCELL Technologies

• Promo Cell GmbH

• Miltenyi Biotec

• ATCC

• HiMedia Laboratories

Please note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report